Edit
SansRosa Pharmaceutical Development, Inc.
http://www.galdermausa.com/Last activity: 17.10.2012
Probably Closed - Reference to Galderma
Topical agents to treat the redness associated with rosacea which was approved by the FDA in 2013. The company was acquired by CollaGenex, Inc. in 2005, which was later acquired by Galderma.
Exited Portfolio Company
www.galdermausa.com
Exited Portfolio Company
www.galdermausa.com
Location: United States
Investors 1
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
Mentions in press and media 2
| Date | Title | Description |
| 17.10.2012 | “Data is the new creative” sparks tiff and 5 more things you missed at a digital pharma conference | A tiff about data eclipsing creative marketing’s importance. A couple of the pharmaceutical trends highlighted in one presentation were about the increasing use of data to quantify consumer behavior, which also has a lot of implications for... |
| - | “Data is the new creative” sparks tiff and 5 more things you missed at a digital pharma conference | One of the most notable things about the digital pharmaceutical sector is that it’s accepted and is now a valid part of pharmaceutical marketing. The impact of having so many tools to track consumer and physician behavior online, and to see... |